Drug lowers high potassium levels associated with potentially lethal cardiac arrhythmias

17 noviembre 2014

Researchers evaluated the efficacy and safety of the drug zirconium cyclosilicate in patients with hyperkalemia — higher than normal potassium levels. Hyperkalemia is a common electrolyte disorder which can cause potentially life-threatening cardiac arrhythmias and is associated with chronic kidney disease, heart failure, and diabetes mellitus.